Supernus Pharmaceuticals Inc
LSE:0LB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Supernus Pharmaceuticals Inc
LSE:0LB2
|
US |
|
JPMorgan Chase & Co
LSE:0Q1F
|
US |
|
Bluestone Resources Inc
F:IX9D
|
CA |
|
AnaptysBio Inc
LSE:0HFQ
|
US |
|
D
|
Dampskibsselskabet Norden A/S
LSE:0HDP
|
DK |
|
C
|
Canadian Tire Corporation Ltd
SWB:YAAA
|
CA |
|
M
|
Murphy Oil Corp
LSE:0K3S
|
US |
|
C
|
Calidi Biotherapeutics Inc
AMEX:CLDI
|
US |
|
C
|
China Vered Financial Holding Corporation Ltd
HKEX:2451
|
HK |
|
Fabasoft AG
LSE:0IWU
|
AT |
|
Revenio Group Oyj
LSE:0KFH
|
FI |
|
A
|
Alfa Laval AB
LSE:0NNF
|
SE |
|
P
|
Phoenix Mecano AG
LSE:0QKP
|
CH |
|
4
|
4Front Ventures Corp
CNSX:FFNT
|
US |
|
Moleculin Biotech Inc
LSE:0K2H
|
US |
|
Adheris Health Ltd
ASX:AHE
|
AU |
Intrinsic Value
The
intrinsic value for
Supernus Pharmaceuticals Inc (0LB2)
under the Base Case is
hidden
USD.
Compared with the current market price of 47.32 USD, the stock appears
hidden
.
0LB2 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 0LB2 is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Supernus Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Supernus Pharmaceuticals Inc
Earnings Waterfall
Supernus Pharmaceuticals Inc
The
intrinsic value for
Supernus Pharmaceuticals Inc (0LB2)
under the Base Case is
hidden
USD.
Compared with the current market price of 47.32 USD, the stock appears hidden .
